Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
6.76T | 6.57T | 6.22T | 11.92T | 3.83T | Gross Profit |
3.54T | 3.33T | 3.27T | 9.17T | 1.24T | EBIT |
560.01B | 380.08B | 713.85B | 6.89T | -918.51B | EBITDA |
1.47T | 1.27T | 365.37B | 7.73T | 2.61T | Net Income Common Stockholders |
-227.65B | -1.01T | -1.74T | 4.99T | -1.16T |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.19T | 7.11T | 5.36T | 4.78T | 3.61T | Total Assets |
46.72T | 43.94T | 47.54T | 45.75T | 37.26T | Total Debt |
21.36T | 20.73T | 22.82T | 20.04T | 14.77T | Net Debt |
15.18T | 13.80T | 17.65T | 15.38T | 11.40T | Total Liabilities |
33.49T | 33.70T | 36.33T | 34.29T | 30.38T | Stockholders Equity |
10.97T | 8.62T | 9.48T | 9.72T | 5.42T |
Cash Flow | Free Cash Flow | |||
-372.06B | 35.71B | -323.63B | -123.89B | -145.74B | Operating Cash Flow |
250.55B | 669.48B | 511.44B | 523.00B | 1.09T | Investing Cash Flow |
-841.46B | 228.18B | -3.06T | -16.86B | -4.37T | Financing Cash Flow |
-606.22B | 191.52B | 602.22B | 2.24T | 2.92T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $184.54B | 10.55 | 18.23% | 6.41% | 0.93% | 56.97% | |
79 Outperform | $30.70B | 26.42 | 9.58% | 2.91% | -0.19% | -0.86% | |
73 Outperform | $195.68B | 16.74 | 11.38% | 4.14% | 0.50% | -12.66% | |
72 Outperform | $52.64B | 34.23 | 7.78% | 2.98% | 3.15% | -63.12% | |
72 Outperform | $268.84B | 23.08 | 19.35% | 1.31% | 5.31% | 38.46% | |
59 Neutral | $13.74B | 6.91 | -2.67% | 3.82% | 2.33% | -34.79% | |
49 Neutral | $73.64B | 12.84 | 8.02% | 0.38% | -2.23% | ― |